Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043228 | non-membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 12 |
GO:0006518 | peptide metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009059 | macromolecule biosynthetic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 12 |
GO:0043043 | peptide biosynthetic process | 5 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043603 | amide metabolic process | 3 | 12 |
GO:0043604 | amide biosynthetic process | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003735 | structural constituent of ribosome | 2 | 12 |
GO:0005198 | structural molecule activity | 1 | 12 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 63 | 67 | PF00656 | 0.437 |
CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 309 | 311 | PF00675 | 0.437 |
CLV_NRD_NRD_1 | 389 | 391 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.435 |
CLV_PCSK_FUR_1 | 386 | 390 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.328 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.424 |
CLV_PCSK_KEX2_1 | 385 | 387 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 388 | 390 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.410 |
CLV_PCSK_KEX2_1 | 425 | 427 | PF00082 | 0.458 |
CLV_PCSK_PC1ET2_1 | 385 | 387 | PF00082 | 0.636 |
CLV_PCSK_PC1ET2_1 | 388 | 390 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 425 | 427 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 350 | 354 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 382 | 386 | PF00082 | 0.679 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.415 |
DEG_APCC_DBOX_1 | 388 | 396 | PF00400 | 0.475 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.623 |
DOC_ANK_TNKS_1 | 215 | 222 | PF00023 | 0.418 |
DOC_CDC14_PxL_1 | 93 | 101 | PF14671 | 0.396 |
DOC_CKS1_1 | 122 | 127 | PF01111 | 0.434 |
DOC_MAPK_gen_1 | 401 | 411 | PF00069 | 0.469 |
DOC_MAPK_gen_1 | 45 | 53 | PF00069 | 0.449 |
DOC_MAPK_MEF2A_6 | 45 | 53 | PF00069 | 0.449 |
DOC_PP1_RVXF_1 | 148 | 155 | PF00149 | 0.328 |
DOC_PP4_MxPP_1 | 316 | 319 | PF00568 | 0.466 |
DOC_USP7_MATH_1 | 278 | 282 | PF00917 | 0.328 |
DOC_USP7_MATH_1 | 384 | 388 | PF00917 | 0.631 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.501 |
DOC_USP7_UBL2_3 | 153 | 157 | PF12436 | 0.344 |
DOC_USP7_UBL2_3 | 253 | 257 | PF12436 | 0.449 |
DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.432 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.328 |
DOC_WW_Pin1_4 | 399 | 404 | PF00397 | 0.635 |
LIG_14-3-3_CanoR_1 | 118 | 123 | PF00244 | 0.418 |
LIG_14-3-3_CanoR_1 | 27 | 33 | PF00244 | 0.568 |
LIG_14-3-3_CanoR_1 | 389 | 393 | PF00244 | 0.484 |
LIG_Actin_WH2_2 | 265 | 282 | PF00022 | 0.344 |
LIG_APCC_ABBA_1 | 300 | 305 | PF00400 | 0.409 |
LIG_APCC_ABBA_1 | 87 | 92 | PF00400 | 0.400 |
LIG_BRCT_BRCA1_1 | 57 | 61 | PF00533 | 0.437 |
LIG_deltaCOP1_diTrp_1 | 345 | 353 | PF00928 | 0.420 |
LIG_EH_1 | 47 | 51 | PF12763 | 0.443 |
LIG_EH1_1 | 235 | 243 | PF00400 | 0.328 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.425 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.344 |
LIG_FHA_2 | 389 | 395 | PF00498 | 0.477 |
LIG_FHA_2 | 400 | 406 | PF00498 | 0.480 |
LIG_Integrin_RGD_1 | 368 | 370 | PF01839 | 0.478 |
LIG_LIR_Apic_2 | 119 | 125 | PF02991 | 0.419 |
LIG_LIR_Apic_2 | 31 | 35 | PF02991 | 0.549 |
LIG_LIR_Gen_1 | 196 | 206 | PF02991 | 0.363 |
LIG_LIR_Gen_1 | 270 | 279 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 196 | 201 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 270 | 276 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 346 | 352 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.400 |
LIG_LYPXL_S_1 | 300 | 304 | PF13949 | 0.428 |
LIG_LYPXL_yS_3 | 301 | 304 | PF13949 | 0.433 |
LIG_MLH1_MIPbox_1 | 57 | 61 | PF16413 | 0.437 |
LIG_MYND_1 | 125 | 129 | PF01753 | 0.407 |
LIG_MYND_1 | 97 | 101 | PF01753 | 0.397 |
LIG_Pex14_1 | 349 | 353 | PF04695 | 0.416 |
LIG_Pex14_2 | 136 | 140 | PF04695 | 0.374 |
LIG_SH2_CRK | 164 | 168 | PF00017 | 0.344 |
LIG_SH2_CRK | 93 | 97 | PF00017 | 0.388 |
LIG_SH2_NCK_1 | 344 | 348 | PF00017 | 0.435 |
LIG_SH2_SRC | 344 | 347 | PF00017 | 0.432 |
LIG_SH2_STAP1 | 147 | 151 | PF00017 | 0.328 |
LIG_SH2_STAP1 | 344 | 348 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.581 |
LIG_SH2_STAT5 | 303 | 306 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 428 | 431 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.428 |
LIG_SH3_2 | 211 | 216 | PF14604 | 0.409 |
LIG_SH3_3 | 208 | 214 | PF00018 | 0.399 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.328 |
LIG_SH3_3 | 408 | 414 | PF00018 | 0.500 |
LIG_SUMO_SIM_par_1 | 199 | 205 | PF11976 | 0.337 |
LIG_TRAF2_1 | 185 | 188 | PF00917 | 0.344 |
LIG_UBA3_1 | 313 | 321 | PF00899 | 0.461 |
LIG_WRC_WIRS_1 | 12 | 17 | PF05994 | 0.626 |
MOD_CDK_SPK_2 | 152 | 157 | PF00069 | 0.344 |
MOD_CDK_SPK_2 | 399 | 404 | PF00069 | 0.484 |
MOD_CK2_1 | 182 | 188 | PF00069 | 0.328 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.328 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.224 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.523 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.454 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.674 |
MOD_GSK3_1 | 384 | 391 | PF00069 | 0.532 |
MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.603 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.493 |
MOD_NEK2_1 | 256 | 261 | PF00069 | 0.328 |
MOD_NEK2_1 | 376 | 381 | PF00069 | 0.635 |
MOD_NEK2_2 | 17 | 22 | PF00069 | 0.367 |
MOD_PIKK_1 | 183 | 189 | PF00454 | 0.344 |
MOD_PIKK_1 | 376 | 382 | PF00454 | 0.679 |
MOD_PKA_1 | 388 | 394 | PF00069 | 0.452 |
MOD_PKA_2 | 388 | 394 | PF00069 | 0.482 |
MOD_PKA_2 | 61 | 67 | PF00069 | 0.438 |
MOD_Plk_1 | 10 | 16 | PF00069 | 0.605 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.420 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.522 |
MOD_Plk_4 | 292 | 298 | PF00069 | 0.418 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.437 |
MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.426 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.328 |
MOD_ProDKin_1 | 399 | 405 | PF00069 | 0.636 |
MOD_SUMO_rev_2 | 356 | 365 | PF00179 | 0.484 |
MOD_SUMO_rev_2 | 88 | 96 | PF00179 | 0.472 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 301 | 304 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 344 | 347 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 133 | 136 | PF00400 | 0.395 |
TRG_ER_diArg_1 | 230 | 232 | PF00400 | 0.413 |
TRG_ER_diArg_1 | 307 | 310 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.416 |
TRG_NLS_MonoExtC_3 | 384 | 389 | PF00514 | 0.583 |
TRG_NLS_MonoExtN_4 | 382 | 389 | PF00514 | 0.593 |
TRG_Pf-PMV_PEXEL_1 | 390 | 394 | PF00026 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I867 | Leptomonas seymouri | 92% | 100% |
A0A0S4IX34 | Bodo saltans | 80% | 100% |
A0A1X0P7T8 | Trypanosomatidae | 87% | 99% |
A0A3Q8INM9 | Leishmania donovani | 97% | 100% |
A0A422NLS3 | Trypanosoma rangeli | 87% | 99% |
A4IDF7 | Leishmania infantum | 97% | 100% |
D0A335 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 85% | 99% |
E9ASV8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4Q1N8 | Leishmania major | 97% | 100% |
V5BJT0 | Trypanosoma cruzi | 86% | 99% |